Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The us...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/431 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849303391044370432 |
|---|---|
| author | Maksim Sergeyevich Eliseyev I S Denisov V G Barskova |
| author_facet | Maksim Sergeyevich Eliseyev I S Denisov V G Barskova |
| author_sort | Maksim Sergeyevich Eliseyev |
| collection | DOAJ |
| description | The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The use of the agent features good compliance and fails to affect renal functional parameters. |
| format | Article |
| id | doaj-art-c72fa29df7c9456792dccb6bc56f517b |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2012-09-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-c72fa29df7c9456792dccb6bc56f517b2025-08-20T03:59:57ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2012-09-0163495210.14412/1996-7012-2012-7461736Experience with Uralyt-U citralite used in patients with gout and nephrolithiasisMaksim Sergeyevich EliseyevI S DenisovV G BarskovaThe paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The use of the agent features good compliance and fails to affect renal functional parameters.https://mrj.ima-press.net/mrj/article/view/431gouturic acidnephrolithiasiscitratesuralyt-u |
| spellingShingle | Maksim Sergeyevich Eliseyev I S Denisov V G Barskova Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis Современная ревматология gout uric acid nephrolithiasis citrates uralyt-u |
| title | Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis |
| title_full | Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis |
| title_fullStr | Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis |
| title_full_unstemmed | Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis |
| title_short | Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis |
| title_sort | experience with uralyt u citralite used in patients with gout and nephrolithiasis |
| topic | gout uric acid nephrolithiasis citrates uralyt-u |
| url | https://mrj.ima-press.net/mrj/article/view/431 |
| work_keys_str_mv | AT maksimsergeyevicheliseyev experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis AT isdenisov experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis AT vgbarskova experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis |